PGEYX
Price
$27.30
Change
+$0.09 (+0.33%)
Updated
Aug 6 closing price
Net Assets
2.22B
RLBEX
Price
$36.99
Change
+$0.09 (+0.24%)
Updated
Aug 6 closing price
Net Assets
253.12B
Interact to see
Advertisement

PGEYX vs RLBEX

Header iconPGEYX vs RLBEX Comparison
Open Charts PGEYX vs RLBEXBanner chart's image
George Putnam Balanced Y
Price$27.30
Change+$0.09 (+0.33%)
VolumeN/A
Net Assets2.22B
American Funds American Balanced R4
Price$36.99
Change+$0.09 (+0.24%)
VolumeN/A
Net Assets253.12B
PGEYX vs RLBEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PGEYX vs. RLBEX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGEYX is a StrongBuy and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 253B vs. PGEYX (2.22B). PGEYX pays higher dividends than RLBEX: PGEYX (2.06) vs RLBEX (1.81). PGEYX was incepted earlier than RLBEX: PGEYX (31 years) vs RLBEX (23 years). PGEYX (0.68) is less costly to investors than RLBEX (0.59). PGEYX is a more actively managed with annual turnover of: 80.00 vs. RLBEX (44.00). PGEYX has a lower initial minimum investment than RLBEX: PGEYX (0) vs RLBEX (250). PGEYX annual gain was more profitable for investors over the last year : 12.17 vs. RLBEX (10.77). RLBEX return over 5 years is better than : 36.60 vs. PGEYX (31.86).
PGEYXRLBEXPGEYX / RLBEX
Total Expense Ratio0.680.59115%
Annual Report Gross Expense Ratio0.680.59115%
Fund Existence31 years23 years-
Gain YTD7.0218.59282%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.22B253B1%
Annual Yield % from dividends2.061.81114%
Returns for 1 year12.1710.77113%
Returns for 3 years36.0431.19116%
Returns for 5 years31.8636.6087%
Returns for 10 years85.4266.90128%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CELZ3.510.55
+18.58%
Creative Medical Technology Holdings
AKAM74.480.83
+1.13%
Akamai Technologies
CLYM1.750.01
+0.57%
Climb Bio Inc
MTRN109.140.58
+0.53%
Materion Corp
FDUS20.750.10
+0.48%
Fidus Investment Corp